Mimi Hu, MD

May 26, 2021

Dr. Mimi Hu graduated from Rice University with a degree in mechanical engineering. She obtained her medical degree from the University of Texas - Houston Health Sciences Center. She completed her residency and endocrine fellowship at the Baylor College of Medicine, where she also served as chief medical resident. After completion of her research fellowship at M. D. Anderson, she joined the faculty in 2007 in the department of Endocrine Neoplasia and Hormonal Disorders. She is the Deputy Department Chair for Clinical Affairs and Program Director of the first-of-its-kind Oncologic Endocrinology Fellowship program since its inception in 2011. She has mentored the clinical research of numerous trainees from residents to fellows, which have been presented at national and international meetings and published. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma (differentiated and medullary), hereditary endocrine neoplasia disorders and metabolic bone and mineral disorders. She is the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She was the primary investigator in a pivotal trial evaluating denosumab in the treatment of hypercalcemia of malignancy, which was approved by the FDA in 2014 for this indication. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, and bone health in cancer patients.

DISCLOSURES:
No Relevant Financial Relationship

Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!